drugset / Trial / NCT00004665
Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
Phase 2
Completed
20 enrolled
National Center for Research Resources (NCRR)
Northwestern University · collab
Treatment
Summary
OBJECTIVES: I. Evaluate the long-term safety and tolerance of a synthetic formulation of dehydroepiandrosterone, GL701, in patients with systemic lupus erythematosus who have completed a prior GL701 protocol.
Timeline
- Start
- 1995-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dehydroepiandrosterone | Other / unclassified | — | Oral |